TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O

Federica Morano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.